Serial antibody progression after 3rd dose of vaccination in thoracic organ transplant patients with inadequate immune response after dual protective vaccination against SARS-CoV-2 coronavirus
Not Applicable
- Conditions
- heart transplantationcoronavirus disease
- Registration Number
- DRKS00028865
- Lead Sponsor
- Herz- und Diabeteszentrum NRW, Klinik für Thorax-und Kardiovaskularchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 390
Inclusion Criteria
Men and women after thoracic organ transplantation (heart, lung, combined heart-lung) with a minimum age of 18 years who have received a first and second vaccination against SARS-CoV-2.
Precondition: Present signed and dated study consent.
Exclusion Criteria
Acute infections;
Medical complications that could increase the risk of vaccination in the opinion of the clinicians treating the patient and/or the physicians responsible for the study, in particular
o Rejection reactions in the past 3 months with the need for augmentation of standard.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method